Vipin K. Garg
Chief Executive Officer at ALTIMMUNE, INC.
Net worth: 2 M $ as of 2024-04-29
Profile
Dr. Vipin K.
Garg is a President, Chief Executive Officer & Director at Altimmune, Inc. and a Chief Executive Officer & Director at Neostx, Inc. He is on the Board of Directors at Altimmune, Inc. and Neostx, Inc. Dr. Garg was previously employed as a President, Chief Executive Officer & Director by Neos Therapeutics, Inc., a President, Chief Executive Officer & Director by OCERA Therapeutics LLC, a Chief Operating Officer by Apex Bioscience, Inc., a Vice President-Development by DNX Bio-Therapeutics, Inc, a Director-Marketing & Technical Services by Sumitomo Dainippon Pharma Co., Ltd., a Manager-Contract Services by Bio Response, Inc., a VP-Product Development & Manufacturing by DNX Corp., a Principal by Sumitomo Pharma America, Inc., and a President & Chief Executive Officer by Tranzyme Pharma, Inc. (Canada).
He also served on the board at The North Carolina Biotechnology Center.
He received his undergraduate degree from Chaudhary Charan Singh University, a graduate degree from Indian Agricultural Research Institute and a doctorate degree from the University of Adelaide.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ALTIMMUNE, INC.
0.41% | 2024-03-21 | 292,028 ( 0.41% ) | 2 M $ | 2024-04-29 |
Vipin K. Garg active positions
| Companies | Position | Start |
|---|---|---|
| ALTIMMUNE, INC. | Chief Executive Officer | 2018-11-29 |
Neostx, Inc.
 Neostx, Inc. Miscellaneous Commercial ServicesCommercial Services Neostx, Inc. develops, manufactures and commercialize branded products. The company was founded in 1994 and is headquartered in Grand Prairie, TX. | Chief Executive Officer | - |
Former positions of Vipin K. Garg
| Companies | Position | End |
|---|---|---|
| NEOS THERAPEUTICS, INC. | Chief Executive Officer | 2018-06-26 |
| OCERA THERAPEUTICS INC | Chief Executive Officer | 2013-11-10 |
Apex Bioscience, Inc.
 Apex Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Apex Bioscience, Inc. develops patented products based upon hemoglobin and nitric oxide technologies. The company was founded by Joseph de Angelo on June 17, 1993 and is headquartered in Chapel Hill, NC. | Chief Operating Officer | 1999-12-31 |
| DNX Bio-Therapeutics, Inc | Corporate Officer/Principal | 1993-12-31 |
| SUMITOMO PHARMA CO., LTD. | Sales & Marketing | 1991-12-31 |
Training of Vipin K. Garg
| University of Adelaide | Doctorate Degree |
| Indian Agricultural Research Institute | Graduate Degree |
| Chaudhary Charan Singh University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| SUMITOMO PHARMA CO., LTD. | Health Technology |
| ALTIMMUNE, INC. | Health Technology |
| Private companies | 10 |
|---|---|
Ocera Therapeutics, Inc.
 Ocera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ocera Therapeutics, Inc. manufactures pharmaceuticals products. The company was founded in 2004 and is headquartered in Hazelwood, MO. | Health Technology |
Apex Bioscience, Inc.
Apex Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Apex Bioscience, Inc. develops patented products based upon hemoglobin and nitric oxide technologies. The company was founded by Joseph de Angelo on June 17, 1993 and is headquartered in Chapel Hill, NC. | Commercial Services |
DNX Corp.
 DNX Corp. Medical SpecialtiesHealth Technology DNX Corp. provides pre-clinical drug development services to the pharmaceutical and biotechnology industry. The private company is based in Princeton, NJ and has subsidiaries in Switzerland and France. The company was founded by John K. Clarke, Steven H. Holtzman. | Health Technology |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Bio Response, Inc.
 Bio Response, Inc. Miscellaneous Commercial ServicesCommercial Services Bio Response, Inc. provides marketing and distribution services. The private company is based in Brooklyn, NY and has subsidiaries in the United States. | Commercial Services |
The North Carolina Biotechnology Center
 The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Technology Services |
Neos Therapeutics, Inc.
 Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX. | Health Technology |
| DNX Bio-Therapeutics, Inc | |
Neostx, Inc.
Neostx, Inc. Miscellaneous Commercial ServicesCommercial Services Neostx, Inc. develops, manufactures and commercialize branded products. The company was founded in 1994 and is headquartered in Grand Prairie, TX. | Commercial Services |
| Tranzyme Pharma, Inc. (Canada) |
- Stock Market
- Insiders
- Vipin K. Garg
